Literature DB >> 24065801

Comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.

Olga Kruszelnicka1, Tomasz Rakowski, Andrzej Surdacki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24065801      PMCID: PMC3781442          DOI: 10.2337/db13-0891

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
Tessari et al. (1) elegantly demonstrated—by a precursor-product stable isotope method—independent contributions of age, type 2 diabetes, and asymmetric dimethylarginine (ADMA) to impaired conversion of 15N-labeled L-arginine into nitrite and nitrate (NOx), products of nitric oxide (NO) metabolism. Interestingly, the authors observed no associations of any parameter of NOx kinetics with insulin sensitivity by a hyperinsulinemic-euglycemic clamp technique (1). Our group was the first to report elevated plasma ADMA in uncomplicated essential hypertension (EH), an insulin-resistant state (2). Additionally, in our hands, in some analogy to Tessari et al. (1), reduced urinary NOx excretion, a surrogate measure of NO generation, was associated with EH by itself and a decreased L-arginine-to-ADMA ratio, being unrelated to clamp-derived indices of accompanying insulin resistance (IR) (2). Therefore, it does not seem implausible to assume that NO deficiency in insulin-resistant conditions, such as EH and type 2 diabetes, may be linked not to the magnitude of IR but to other mechanisms, such as ADMA accumulation. Inasmuch as whole-body NO formation can putatively reflect endothelial function, these findings (1,2) appear consistent with associations of ADMA, but not IR, with impaired endothelium-dependent vasodilation in EH (3) and early coronary atherosclerosis (4). The proposed hypothesis is contradictory to the notion of NO—liberated by endothelial cells in response to insulin via the Akt-dependent pathway (5)—coupling glucose metabolism to vasodilation in skeletal muscle (6). However, Kearney (5) has recently summarized novel evidence supporting the dissociation of metabolic sensitivity to insulin from endothelial NO release and its vasculoprotective effects. Nevertheless, NOx assay does not allow differentiation between biologically active NO and that scavenged by superoxide, which might obscure the correlation between IR and depressed NO bioavailability. Sukumar et al. (7) described the dependence of IR-induced endothelial dysfunction on enhanced superoxide generation by a NADPH oxidase. Hence, further mechanistic studies on impaired NO bioavailability in IR states are warranted.
  7 in total

1.  Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis.

Authors:  Ahmad A Elesber; Hemant Solomon; Ryan J Lennon; Verghese Mathew; Abhiram Prasad; Geralyn Pumper; Rebecca E Nelson; Joseph P McConnell; Lilach O Lerman; Amir Lerman
Journal:  Eur Heart J       Date:  2006-01-24       Impact factor: 29.983

2.  Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension.

Authors:  A Surdacki; M Nowicki; J Sandmann; D Tsikas; R H Boeger; S M Bode-Boeger; O Kruszelnicka-Kwiatkowska; F Kokot; J S Dubiel; J C Froelich
Journal:  J Cardiovasc Pharmacol       Date:  1999-04       Impact factor: 3.105

Review 3.  The coupling of glucose metabolism and perfusion in human skeletal muscle. The potential role of endothelium-derived nitric oxide.

Authors:  A D Baron
Journal:  Diabetes       Date:  1996-01       Impact factor: 9.461

4.  Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients.

Authors:  Shin Takiuchi; Hideki Fujii; Kei Kamide; Takeshi Horio; Satoshi Nakatani; Aki Hiuge; Hiromi Rakugi; Toshio Ogihara; Yuhei Kawano
Journal:  Am J Hypertens       Date:  2004-09       Impact factor: 2.689

5.  Changing the way we think about endothelial cell insulin sensitivity, nitric oxide, and the pathophysiology of type 2 diabetes: the FoxO is loose.

Authors:  Mark T Kearney
Journal:  Diabetes       Date:  2013-05       Impact factor: 9.461

6.  Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo.

Authors:  Paolo Tessari; Diego Cecchet; Carlo Artusi; Monica Vettore; Renato Millioni; Mario Plebani; Lucia Puricelli; Monica Vedovato
Journal:  Diabetes       Date:  2013-03-08       Impact factor: 9.461

7.  Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction.

Authors:  Piruthivi Sukumar; Hema Viswambharan; Helen Imrie; Richard M Cubbon; Nadira Yuldasheva; Matthew Gage; Stacey Galloway; Anna Skromna; Parkavi Kandavelu; Celio X Santos; V Kate Gatenby; Jessica Smith; David J Beech; Stephen B Wheatcroft; Keith M Channon; Ajay M Shah; Mark T Kearney
Journal:  Diabetes       Date:  2013-01-24       Impact factor: 9.461

  7 in total
  1 in total

1.  Response to comment on: Tessari et al. Roles of insulin, age, and asymmetric dimethylarginine on nitric oxide synthesis in vivo. Diabetes 2013;62:2699-2708.

Authors:  Paolo Tessari
Journal:  Diabetes       Date:  2013-10       Impact factor: 9.461

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.